While in normal cells, this feedback also limits the duration of the response to stimuli, in cells bearing mutations constitutively activating the signaling, the negative feedback helps maintain optimal ERK pathway intensity compatible with tumor cell survival and growth (4, 41). This evidence concerns the gene MAPK1 and neoplasm.